Evidence map›Paper›PMID 40486300›Full record

ReviewCureus2025

Global Preventive and Management Strategies and Their Effectiveness in Patients With Secondary Lymphedema: A Scoping Review.

Vicent Mwesigye, Daniel Atwine, Esther Faith Munguciada, Alice Tillema, Joanita Berytah Tebulwa, Bosco Bekita Agaba, Joel Bazira, Francis Bajunirwe, Itabangi Herbaert, Frederick Byarugaba and 1 more

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vicent MwesigyeDepartment of Medical Laboratory Science, Mbarara University of Science and Technology, Mbarara, UGA.
Daniel AtwineDepartment of Research Services, Soar Research Foundation, Mbarara, UGA.
Esther Faith MunguciadaDepartment of Clinical Research, Soar Research Foundation (SRF) Research and Training Centre, Mbarara, UGA.
Alice TillemaDepartment of Information and Library Services, Radboud University, Nijmegen, NLD.
Joanita Berytah TebulwaDepartment of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, UGA.
Bosco Bekita AgabaDepartment of Medical Laboratory Science, Mbarara University of Science and Technology, Mbarara, UGA.
Joel BaziraDepartment of Microbiology and Parasitology, Mbarara University of Science and Technology, Mbarara, UGA.
Francis BajunirweDepartment of Community Health, Mbarara University of Science and Technology, Mbarara, UGA.
Itabangi HerbaertDepartment of Microbiology, Busitema University, Busitema, UGA.
Frederick ByarugabaDepartment of Microbiology and Parasitology, Mbarara University of Science and Technology, Mbarara, UGA.
Edgar MulogoDepartment of Community Health, Mbarara University of Science and Technology, Mbarara, UGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary lymphedema arises from lymphatic damage, often due to infections, inflammatory conditions, cancer treatments, or trauma, leading to fluid retention, swelling, and mobility issues that impact the quality of life. This scoping review examined global preventive and management strategies for secondary lymphedema, assessing their effectiveness and feasibility, particularly in low-resource settings. Additionally, it explored causative agents and knowledge gaps among patients and healthcare workers in endemic communities. This review followed the Joanna Briggs Institute (JBI) methodology and reported findings using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) guidelines. The search strategy targeted four databases, including PubMed, Embase, Web of Science, and African Index Medicus. The inclusion criteria included all studies that focused on lower or upper limb secondary lymphedema, and reported on either preventive or management interventions or strategies globally, and were published between 2014 and 2024 in English. Data extraction involved two reviewers, with discrepancies resolved through discussion. A descriptive and narrative synthesis was performed to highlight preventive and management strategies and their effectiveness. A total of 3192 published articles were retrieved from searches of the selected databases, that is, PubMed (n=1467), Embase conference (n=386), Embase articles (n=550), Web of Science (n=713), and Africa Index Medicus (n=76). After the elimination of duplicate and ineligible articles, 45 articles were included in the final qualitative synthesis. Microsurgical techniques are more effective than conservative treatments. Self-care and hygiene-based strategies were more widely used for filarial lymphedema and podoconiosis in endemic areas, whereas the Mass Drug Administration (MDA) and Morbidity Management and Disability Prevention (MMDP) programs had limited success in halting disease progression. Adjunct therapies, including low-level laser therapy, cryotherapy, and kinesio taping, have shown potential in enhancing limb function and quality of life. The primary causes of secondary lymphedema vary geographically, with lymphatic filariasis dominant in tropical regions, podoconiosis in volcanic highlands, and cancer-related lymphedema in high-income areas. Knowledge gaps and misconceptions among patients, healthcare workers, and communities hinder effective disease management, with stigma and misinformation remaining key barriers despite educational efforts. While microsurgical interventions offer quick, effective clinical outcomes, hygiene-based interventions and self-care practices are the most scalable strategies for the treatment and management of filarial and podoconiosis-related lymphedema in low-resource settings.

Indexed as

filariasiskamwengelymphedemaneglected tropical diseasespodoconiosisuganda

Identifiers

PMID40486300
PMCPMC12142275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.